Moneycontrol PRO
HomeNewsNatco pharma

Natco Pharma

Jump to
  • Natco Pharma Standalone June 2025 Net Sales at Rs 1,192.70 crore, down 3.57% Y-o-Y

  • Stocks to Watch Today: Infosys, Dr Reddys Labs, Tata Consumer, Cigniti, Force Motors, Natco Pharma, IndusInd Bank, BEML, Tilaknagar Ind in focus on 24 July

    Stocks to Watch Today: Infosys, Dr Reddys Labs, Tata Consumer, Cigniti, Force Motors, Natco Pharma, IndusInd Bank, BEML, Tilaknagar Ind in focus on 24 July

    Stocks to Watch, 24 July: Stccks like Infosys, Dr Reddys Laboratories, Tata Consumer Products, Cigniti Technologies, Force Motors, Natco Pharma, IndusInd Bank, BEML, and Tilaknagar Industries will be in focus on July 24.

  • Natco Pharma offers to buy 35.75% stake in South Africa's Adcock Ingram for Rs 2,000 crore

    Natco Pharma offers to buy 35.75% stake in South Africa's Adcock Ingram for Rs 2,000 crore

    Natco Pharma to set up arm in South Africa with investment of Rs 2,100 crore

  • Natco Pharma plans to acquire majority stake in South Africa-based Adcock Ingram Holdings: CNBC-Awaaz

    Natco Pharma plans to acquire majority stake in South Africa-based Adcock Ingram Holdings: CNBC-Awaaz

    Adcock Ingram offers generics and OTC medicines in Africa. CNBC-Awaaz reported that Natco may buy majority stake in the firm

  • Natco Pharma shares fall on seven observations from USFDA

    Natco Pharma shares fall on seven observations from USFDA

    Natco Pharma share price | The USFDA concluded the inspection at company's unit at Kothur, Hyderabad, India with seven observations.

  • Stocks to Watch Today: Sai Life Sciences, Kaynes Tech, GMM Pfaudler, Axiscades Tech, Natco Pharma, ITD Cementation, Oswal Pumps in focus on 20 June

    Stocks to Watch Today: Sai Life Sciences, Kaynes Tech, GMM Pfaudler, Axiscades Tech, Natco Pharma, ITD Cementation, Oswal Pumps in focus on 20 June

    Stocks to Watch, 20 June: Stocks like Brigade Enterprises, TD Power Systems, JSW Infrastructure, Biocon, United Spirits, Can Fin Homes, Container Corporation of India, Sai Life Sciences, Kaynes Technology India, GMM Pfaudler, Axiscades Technologies, ITD Cementation India, Natco Pharma, and Le Travenues Technology will be in focus on June 20.

  • Stocks to Watch Today: ITC, Bajaj Finance, Sun Pharmaceutical, Syngene, Natco Pharma, Vedanta, Sacheerome in focus on 16 June

    Stocks to Watch Today: ITC, Bajaj Finance, Sun Pharmaceutical, Syngene, Natco Pharma, Vedanta, Sacheerome in focus on 16 June

    Stocks to watch, 16 June: Gujarat Themis Biosyn, Godrej Properties, Sun Pharmaceutical Industries, Belrise Industries, Syngene International, Natco Pharma, Vedanta, ITC, Eicher Motors, South Indian Bank, NTPC, Nazara Technologies, Scoda Tubes, Shalby, Jubilant Pharmova, Jubilant Foodworks, and Jubilant Ingrevia will be in focus on June 16.

  • Natco Pharma Standalone March 2025 Net Sales at Rs 1,157.40 crore, up 19.96% Y-o-Y

    Natco Pharma Standalone March 2025 Net Sales at Rs 1,157.40 crore, up 19.96% Y-o-Y

  • Natco Pharma Consolidated March 2025 Net Sales at Rs 1,221.00 crore, up 14.29% Y-o-Y

    Natco Pharma Consolidated March 2025 Net Sales at Rs 1,221.00 crore, up 14.29% Y-o-Y

  • Hold Natco Pharma; target of Rs 890: ICICI Securities

    Hold Natco Pharma; target of Rs 890: ICICI Securities

    ICICI Securities recommended hold rating on Natco Pharma with a target price of Rs 890 in its research report dated May 30, 2025.

  • Stocks to Watch Today: SAIL, Avanti Feeds, Insecticides India, Balaji Amines, Cummins, Mishra Dhatu Nigam, IRCTC, Unified Data Tech in focus on 29 May

    Stocks to Watch Today: SAIL, Avanti Feeds, Insecticides India, Balaji Amines, Cummins, Mishra Dhatu Nigam, IRCTC, Unified Data Tech in focus on 29 May

    Stocks to watch, 29 May: Stocks like Bharat Rasayan, HeidelbergCement India, Birlasoft,Som Distilleries and Breweries, Natco Pharma, Deepak Nitrite, RITES, Aurobindo Pharma, IndusInd Bank, Steel Authority of India, Avanti Feeds, Insecticides India, Balaji Amines, Cummins India, ITC, ADF Foods, Mishra Dhatu Nigam, and Unified Data Tech Solutions will be in focus on May 29.

  • Natco Pharma Consolidated December 2024 Net Sales at Rs 474.80 crore, down 37.41% Y-o-Y

    Natco Pharma Consolidated December 2024 Net Sales at Rs 474.80 crore, down 37.41% Y-o-Y

  • Natco Pharma Standalone December 2024 Net Sales at Rs 407.60 crore, down 34.82% Y-o-Y

    Natco Pharma Standalone December 2024 Net Sales at Rs 407.60 crore, down 34.82% Y-o-Y

  • Natco Pharma shares bleed 18.5% as Q3 earnings show disappoints

    Natco Pharma shares bleed 18.5% as Q3 earnings show disappoints

    Natco Pharma's Q3 earnings were heavily dented by a sharp drag in its export formulations segment, which accounted for 44 percent of its total sales.

  • Natco Pharma Consolidated September 2024 Net Sales at Rs 1,371.10 crore, up 32.94% Y-o-Y

    Natco Pharma Consolidated September 2024 Net Sales at Rs 1,371.10 crore, up 32.94% Y-o-Y

  • Natco Pharma Standalone September 2024 Net Sales at Rs 1,292.60 crore, up 38.91% Y-o-Y

    Natco Pharma Standalone September 2024 Net Sales at Rs 1,292.60 crore, up 38.91% Y-o-Y

  • Natco Pharma Q2 net profit jumps 83% to Rs 676 crore

    Natco Pharma Q2 net profit jumps 83% to Rs 676 crore

    Revenue from operations rose to Rs 1,371 crore as compared with Rs 1,031 crore in the year-ago period

  • Gainers & losers: Stocks and sectors that moved the most on October 7

    Gainers & losers: Stocks and sectors that moved the most on October 7

    Benchmark indices ended the day in the red for the sixth straight session, albeit off the day's lows. At close, the Sensex was down 638.45 points or 0.78 percent at 81,050, and the Nifty was down 218.80 points or 0.87 percent at 24,795.80.

  • Trade Spotlight: How should you trade Bajaj Finance, Nestle, Indian Hotels, Natco Pharma, Havells and others on Thursday?

    Trade Spotlight: How should you trade Bajaj Finance, Nestle, Indian Hotels, Natco Pharma, Havells and others on Thursday?

    The Nifty 50 is expected to remain rangebound before moving in a firm direction. Below are some trading ideas for the near term.

  • Hold Natco Pharma; target of Rs 1430: ICICI Securities

    Hold Natco Pharma; target of Rs 1430: ICICI Securities

    ICICI Securities recommended hold rating on Natco Pharma with a target price of Rs 1430 in its research report dated August 13, 2024.

  • Natco Pharma Consolidated June 2024 Net Sales at Rs 1,362.60 crore, up 19.47% Y-o-Y

    Natco Pharma Consolidated June 2024 Net Sales at Rs 1,362.60 crore, up 19.47% Y-o-Y

  • Natco Pharma Standalone June 2024 Net Sales at Rs 1,236.90 crore, up 17.99% Y-o-Y

    Natco Pharma Standalone June 2024 Net Sales at Rs 1,236.90 crore, up 17.99% Y-o-Y

  • Natco Pharma Consolidated March 2024 Net Sales at Rs 1,068.30 crore, up 18.98% Y-o-Y

    Natco Pharma Consolidated March 2024 Net Sales at Rs 1,068.30 crore, up 18.98% Y-o-Y

  • Stock Radar: LIC, Natco Pharma, Lumax Auto Tech, Adani Energy, Concord Biotech, Timken India in focus on Tuesday

    Stock Radar: LIC, Natco Pharma, Lumax Auto Tech, Adani Energy, Concord Biotech, Timken India in focus on Tuesday

    Engineers India, Aditya Birla Fashion and Retail, Amara Raja Energy & Mobility, Aster DM Healthcare, EIH, Exicom Tele-Systems, and IRCTC are among the 440 companies set to announce their March quarter earnings on Tuesday.

  • Natco Pharma Standalone March 2024 Net Sales at Rs 964.80 crore, up 23.5% Y-o-Y

    Natco Pharma Standalone March 2024 Net Sales at Rs 964.80 crore, up 23.5% Y-o-Y

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347